NASDAQ$BTTC

Black Titan Corp · Q3 2019 earnings

Q3 2019 earnings · Reported Nov 14, 2019 (7 years ago) · Investor relations

Nov 14Sep 30, 2019

Total Revenue

$83K

Previous: $562K-85.2%

EPS (adj)

-$108.00

Previous: -$396.00+72.7%

Capital Expenditures

$61K

Previous: $0.00

Free Cash Flow

-$3.39M

Previous: -$60.3K-5519.5%

Net Income

-$687K

Previous: -$54.1K-1170.1%

Operating Income

-$672K

Previous: -$42.9K-1465.6%

Gross Profit

-$6.51K

Previous: $352K-101.9%

Cash & Equivalents

$189K

Previous: $47.6K+298.0%

Total Assets

$1.71M

Previous: $4.12M-58.5%

Stock-Based Comp

$128K

Previous: $388K-67.0%

Titan Pharmaceuticals · Revenue · Quarterly

$83K

Q3 2019-85.2%vs Q3 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation